reason report
report set strong medicaid/mlr hullabaloo
bottom line see print top- bottom-
line beat guidanc reaffirm set strong
reiter pt hullabaloo
call last quarter year seem way overdon
us given compani in-lin consensu guidanc
full-year normal season big contributor
qoq uptick addit isol clearli transient medicaid
pressur medicar advantag commerci book uhc
solid global offer opportun margin expans optum
see top-lin growth margin expans three segment
downsid risk cigna optum rx contract loss manag given
low margin adj rx exposur low margin link
expect beat rais across organ tailwind util
uhc normal medicaid close dmg transact
deploy current guidanc
sector defens potenti macroeconomic downturn
structur moder util slow recess
even tailwind rise interest rate manag team
stellar deep bench view see price-to-earnings
ep bull case price-to-earnings strong buy opportun
modestli tweak estim reflect cadenc commentari
lower tax rate maintain ep
solid print top- bottom-lin beat guidanc
re-affirm ep beat uhc margin
in-lin optum margin beat day claim payabl
hullabaloo overblown hullabaloo
call last quarter year seem way overdon
us given compani in-lin consensu guidanc
full-year addit isol clearli transient
medicaid pressur normal season big contributor
qoq uptick penetr size deduct exhibit
util remain well control consist hospit
survey across commerci medicar prior period
develop mm mm intra-year also solid global
amil offer room margin expans exhibit
modestli tweak estim reflect cadenc
commentari lower tax rate maintain
ep exhibit
base price-to-earnings
ep
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
year price history/av daili volume mil
compani inform svb leerink llc research
revenu billion ep dilut show ep exclud non-cash amort year quarterli
number may sum full-year number due round
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
optum continu perform strongli top-lin growth
margin expans three busi unit optum
earn compar five year ago drive continu
defens macroeconomic downturn upsid
rise interest rate hospit volum correl macro-
econom indic includ growth non-farm payrol
see structur moder rise deduct mix shift
lower cost site servic rise interest rate also offer tailwind
invest incom pleas link outlook call
organ structur talent model deep bench
make strong competit advantag passion excel
humil restless desir win cultur keep
top game expect make hard fast-follow
larg cap space new entrant
catch
attract entri point high qualiti growth name view
name trade base case ep
like bull case ep contempl upsid inorgan activ
includ dmg pois close balanc sheet unparallel
univers cfo even
debt paydown share repurchas dividend pay-out exhibit
see print top- bottom-lin beat guidanc re-affirm
set strong reiter pt hullabaloo
call last quarter year seem way overdon us given compani
in-lin consensu guidanc full-year normal season
big contributor qoq uptick addit isol clearli transient medicaid
pressur medicar advantag commerci book uhc solid global offer opportun
margin expans optum see top-lin growth margin expans three
segment downsid risk cigna optum rx contract loss manag given low margin
adj rx exposur low margin link expect beat rais across
organ tailwind util uhc normal medicaid close dmg
transact deploy current guidanc sector
defens potenti macroeconomic downturn structur moder util
slow recess even tailwind rise interest rate
manag team stellar deep bench view see price-to-earnings
ep bull case price-to-earnings strong buy opportun modestli tweak
estim reflect cadenc commentari lower tax rate maintain ep
solid print top- bottom-lin beat guidanc re-affirm ep
beat uhc margin in-lin optum margin beat day
claim payabl steadi yoy
unitedheatlhgroup earningsreport leerink estimatesconsensu estimatesreport sequentialreport rx inc
unitedheatlhgroup metricsreport leerink estimatesconsensu estimatesreport sequenti bp metricsconsolid oper oper oper tax cost day cfo/net membership leerink estimatesconsensu estimatesreport sequentialreport servedcommerci medicar public medic part inc
maintain ep guidanc rang
svb leerinkconsensusrevenu amort earn weighted-avg share net net ep excl amort flow oper paid repurchas expenditur guidanc investor share membership membership market share unhtot industrymarket share unitedhealth group inc
much weaker op profit contribut
hullabaloo call last quarter year seem
way overdon us given compani in-lin consensu guidanc
full-year addit isol clearli transient medicaid pressur
normal season big contributor qoq uptick penetr size
consensu vs svb leerink estim announc
group fi membership group si membership adj leerink consensu estim pre earn inc
util remain well control consist hospit survey across
commerci medicar prior period develop mm mm intra-year also
solid global amil offer room margin expans
overal medic cost remain well-control posit forecast remain consist across line busi david scott wichmann ceo director inc calloveral medic cost trend remain well manag predict consist expect continu manag oper cost dilig combin busi simplif autom oper effici steven nelson evp ceo unitedhealthcar inc callwith regard commerci cost trend year-ago guid rang narrow investor confer novemb would tell year land squar within pleas cost came commerci perspect well translat in-lin earn expect dan schumach presid unitedhealthcar inc call inc
modestli tweak estim reflect cadenc commentari lower tax
rate maintain ep
tweak estim modestli reflect ep cadenc keep ep estim
optum continu perform strongli top-lin growth margin expans
three busi unit optum earn compar five year ago
drive continu multipl expans
margin expand yoy optum optum insight optum growth remain impress
report leerink estimatesconsensu estim beat/miss leerink report leerink estimatesconsensu estim leerink estimatesreport marginsearn mm revenu mm inc
optum insight backlog remain strong grew yoy
optum health serv mm consum end
defens macroeconomic downturn upsid rise interest
rate hospit volum correl macroeconomic indic includ growth
non-farm payrol see structur moder rise deduct mix
shift lower cost site servic rise interest rate also offer tailwind invest incom
pleas link outlook call
organ structur talent model deep bench make strong competit
advantag passion excel humil restless desir win cultur
keep top game expect make hard fast-follow larg
cap space new entrant catch
name trade base case ep like bull case ep
contempl upsid inorgan activ includ dmg pois close
balanc sheet unparallel univers cfo
even debt paydown share repurchas dividend pay-out
trade price-to-earnings consensu ep estim
rel ntm price-to-earnings optum uhc togeth command peer averag valuat
given growth profil
debt capit current
incom servic oper costsmed product oper incom incom earn growth net share dilut earn per ep ep chang growth sg ratio oper inc
care risk-bas risk-bas advantag medicar public servic medic part prescript drug inc
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
pt contempl price-to-earnings ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base absolut price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
price target base price-to-earnings multipl price-to-earnings ep
price-to-earnings ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
integr regulatori risk across merg ci esrx
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price target base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
pt contempl price-to-earnings consensu ep
price-to-earnings ep expect synergi across administr effici
retail steerag aet member benefit design chang floor rebat reduct
store base distribut part polici drive upsid estim also
multipl expans pt
underwrit risk aet asset trade peak margin commerci fulli
insur though medacorp commerci broker price survey give us confid
price environ remain appropri hard offer flat even potenti
modestli expand underwrit margin risk potenti futur margin compress
aet health insur even meaning given associ neg impact
debt ebitda load compani need focus debt
pay next month departur shawn guertin aet cfo
slate becom cfo make us less confid price postur
health insur book commenc new bulk compet
share gain commerci medicar advantag market
macroeconom risk risk macroeconom downturn higher
defens pbm sub sector given cyclic correl retail front store
sale employ data
regulatori risk convinc pbm add valu earn
low probabl threat potenti drug manufactur rebat elimin off-set
new busi model includ administr fee and/or perform guarante
expos pbm retail pharmaci busi compar
player pbm risk
execut integr risk face greater risk well given integr
pbm broader organ also transform agenda around
build retail front model amid risk leverag balanc sheet
e-commerce/amzn greater exposur eros sale on-line
channel well given exposur retail front store retail pharmaci e-
commerc though larg price retail multipl expect less like
pursu agenda becom pbm given associ integr clinic evid
base treatment guidelin integr provid network domin captiv pbm
model mega deal
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
